Market News

Latest financial and economic news and analysis

PRNewsWire News Agency
4 days ago•PRNewsWire
Stocks Medium Importance Neutral
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

Collaboration combines Odyssey's disease biology expertise with Evotec's AI-enabled discovery platform, advanced screening capabilities and proprietary compound libraries to support advancement of Odyssey's discovery-stage programs Evotec to deliver validated hit series across multiple high-value targets for large inflammatory and autoimmune diseases with high unmet medical need HAMBURG, Germany, Aug. 6, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced that it has entered a strategic R&D collaboration with Odyssey Therapeutics, Inc. (NASDAQ: ODTX) to discover potential new treatments in autoimmune and inflammatory diseases. Under the agreement, Odyssey will leverage Evotec's integrated data-driven discovery platform, advanced screening capabilities and AI-enabled data science technologies to discover and validate differentiated small molecule drug candidates across multiple high-value disease targets.

Related Symbols 1
EVO EVO
Source: PRNewsWire
Visit Source
0 0 0
Read More
Comment
Reuters News Agency
4 days ago•Reuters
Stocks Medium Importance Neutral
OpenAI asks US judge to dismiss Apple's trade secrets case

OpenAI asks US judge to dismiss Apple's trade secrets case

OpenAI asked a U.S. judge on Wednesday to dismiss Apple's lawsuit ​accusing it and two former ‌Apple employees of misappropriating the iPhone maker's trade secrets to benefit the ChatGPT maker's ​foray into consumer hardware.

Related Symbols 1
AAPL Apple Inc.
Source: Reuters
Visit Source
0 0 0
Read More
Comment
Accesswire News Agency
4 days ago•Accesswire
Stocks Medium Importance Neutral
Valeura Energy Inc. Announces Record Operational and Financial Performance in Q2 2026

Valeura Energy Inc. Announces Record Operational and Financial Performance in Q2 2026

CALGARY, AB / ACCESS Newswire / August 6, 2026 / Valeura Energy Inc. (TSX:VLE)(OTCQX:VLERF) ("Valeura" or the "Company") reports its unaudited financial and operating results for the three and six month periods ended 30 June 2026. The complete quarterly reporting package for the Company, including the unaudited financial statements (the "Interim Financial Statement") and associated management's discussion and analysis ("MD&A") are being filed on SEDAR+ at www.sedarplus.caand posted the Company's website at www.valeuraenergy.com.

Related Symbols 1
VLE VLE
Source: Accesswire
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Seeking Alpha News Agency
4 days ago•Seeking Alpha
Stocks Medium Importance Neutral
Eli Lilly Q2: Strong Results Further Strengthen The Investment Thesis

Eli Lilly Q2: Strong Results Further Strengthen The Investment Thesis

Eli Lilly remains a buy after Q2, with robust revenue growth and strong performance from Mounjaro and Zepbound. LLY raised 2026 revenue guidance to $85–87 billion, driven by volume gains despite price declines, and reinforced margin expansion. Retatrutide is a key medium-term catalyst, with a BLA submission planned for Q1 2027 and potential in new therapeutic areas.

Related Symbols 1
LLY LLY
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment
CNBC News Agency
4 days ago•CNBC
Stocks Medium Importance Neutral
Google is expanding its AI empire — and losing the people who built it

Google is expanding its AI empire — and losing the people who built it

Google's cloud boom is testing the company's commitment to frontier AI as commercial returns take priority. Jeff Dean's departure and Demis Hassabis' move away from daily management of DeepMind add to questions about Google's ability to retain top talent and stay at the frontier.

Related Symbols 1
GOOG GOOG
Source: CNBC
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
MarketBeat News Agency
4 days ago•MarketBeat
Stocks Medium Importance Neutral
ONE Group Hospitality Q2 Earnings Call Highlights

ONE Group Hospitality Q2 Earnings Call Highlights

ONE Group Hospitality NASDAQ: STKS reported second-quarter revenue declined from a year earlier, as planned restaurant portfolio optimization and a delayed New York City relocation weighed on reported sales. However, the company said comparable sales, transactions and restaurant-level margins improved across its operating segments.

Related Symbols 1
STKS STKS
Source: MarketBeat
Visit Source
0 0 0
Read More
Comment
Seeking Alpha News Agency
4 days ago•Seeking Alpha
Stocks Medium Importance Neutral
Palantir's Pathway Back To $200 Just Became A Lot Clearer

Palantir's Pathway Back To $200 Just Became A Lot Clearer

Palantir delivered another quarter of exceptional growth, notably in its US commercial segment. Palantir continues to accelerate growth despite challenging year-over-year comparisons, defying typical business trends. Palantir has booked some major new customer wins in competitive sectors.

Related Symbols 1
PLTR PLTR
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment
Seeking Alpha News Agency
4 days ago•Seeking Alpha
Stocks Medium Importance Neutral
Pacific Biosciences: It's Only Getting Worse

Pacific Biosciences: It's Only Getting Worse

Pacific Biosciences reported Q2 revenues of $39.01 million, missing estimates and guiding 2026 revenues down, below consensus. Operating and net losses remain sizable, with cash now under $237 million and nearly $645 million in debt outstanding. PACB trades at 2.4x expected 2026 revenues, a steep discount to peers, reflecting weaker financials and growth prospects.

Related Symbols 1
PACB PACB
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment